MUSK - Overview: Muscle-Specific Kinase (MuSK) Autoantibody, Serum
Diagnosis of autoimmune muscle-specific kinase (MuSK) myasthenia gravis Second-order test to aid in the diagnosis of autoimmune myasthenia gravis when first-line serologic tests are negative Establishing a quantitative baseline value...
SMAT - Overview: Smooth Muscle Antibody Titer, Serum
Antibody titer testing as a part of the evaluation of patients with hepatitis of unknown origin associated with hypergammaglobulinemia and/or abnormal liver enzymes
SOMAT - Overview: Somatostatin Immunostain, Technical Component Only
Aids in the characterization of pancreatic islet cell tumors or other neuroendocrine tumors
SORD - Overview: Sorbitol and Xylitol, Quantitative, Random, Urine
Screening for sorbitol dehydrogenase deficiency-related neuropathy
TACPK - Overview: Tacrolimus, Peak, Blood
Assessment of postdosing (peak) blood tacrolimus concentrations
P63 - Overview: p63 Immunostain, Technical Component Only
Aiding in identifying squamous, urothelial, or myoepithelial differentiation in tumors
RBR - Overview: Retinol-Binding Protein, Random, Urine
Assessing renal tubular injury or dysfunction using random urine collections Screening for other tubular abnormalities Detecting chronic asymptomatic renal tubular dysfunction.(2)
GAL2 - Overview: Probability of Hepatocellular Carcinoma, Serum
Calculation of the risk for patients with chronic liver disease to develop hepatocellular carcinoma
TYROS - Overview: Tyrosinase (TYROS) Immunostain, Technical Component Only
Aiding in the identification of normal melanocytes and malignant melanoma
Diagnosing fat malabsorption due to pancreatic or intestinal disorders Monitoring effectiveness of enzyme supplementation in certain malabsorption disorders This test is not useful for differentiating among pancreatic diseases.
Mayo Clinic Ranked No. 1 Hospital Nationwide by U.S. News & World Report - Insights
Report’s 29th annual "Best Hospitals Honor Roll" published online on August 14. Mayo Clinic also ranked No. 1 in more specialties than any other hospital in the country....
NELL-1 [Test in Focus] - Insights
D., discusses how Mayo Clinic Laboratories’ new immunohistochemistry test for the detection of NELL-1 antigen, a biomarker for membranous nephropathy found in 10% to 15% of patients, provides diagnostic...
Looking Back on Clinical Chemistry 1 - Insights
in the Mayo Clinic Medical Laboratory Science program, takes a look back on her Clinical Chemistry 1 course....
Orexin-A/Hypocretin-1 for the Diagnosis of Type 1 Narcolepsy [Test in Focus] - Insights
test to perform as well as to interpret. The orexin-A/hypocretin-1 test is a sensitive and specific alternative to the MSLT to diagnose type 1 narcolepsy....
Week in Review: November 1 - Insights
Top highlights include: Facebook launches into the digital space of healthcare, medical breakthrough for Ebola, and how the brain makes memories.